Tetanus shots were associated with less occurrence and a slower progression of Parkinson’s disease in a preprint paper on medRxiv.
Bone marrow transplants from young mice appeared to influence amyloid-beta levels and behavioral deficits in a mouse model of Alzheimer’s disease. (Science Advances)
Meta-analyses of genome-wide association studies produced new insights about the genetic profile, biology, and risk of restless legs syndrome. (Nature Genetics)
A model based on changes in the brain’s default mode network predicted future dementia incidence and time to diagnosis. (Nature Mental Health)
A working group looked at the ethical, legal, and policy challenges of neuroimaging research using portable MRI. (Journal of Law and the Biosciences)
About 7% of U.S. adults have had long COVID, Medical Expenditure Panel Survey (MEPS) data showed. (JAMA)
Serial measurements of serum glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) helped track recovery in amateur athletes with sport-related concussion. (JAMA Network Open)
Investigational dalzanemdor (SAGE-718) was well tolerated in the phase II SURVEYOR study of Huntington’s disease, but the trial was not powered to show significant cognitive changes, Sage Therapeutics said.
Elevated Epstein-Barr virus antibody responses appeared to extend beyond EBNA1 in people with multiple sclerosis. (PLOS Pathogens)
A small study looked at neurovascular interactions in Huntington’s disease. (Brain Communications)
More research investigated the relationship between depression and cognitive performance in older adults. (JAMA Network Open)
CNN chronicled the experiences of the first patient diagnosed with rapid eye movement (REM) sleep behavior disorder.
An essayist with Alzheimer’s examined the lessons he learned from his mother, who also had the disease. (New York Times)
Please enable JavaScript to view the